Unresectable Triple-Negative Breast Carcinoma trials recruiting in Massachusetts
Fewer than 3 recruiting trials found.
All Unresectable Triple-Negative Breast Carcinoma trials nationally
2
Recruiting in Massachusetts
1
Cities with sites
Cities in Massachusetts
Boston 2
Recruiting trials in Massachusetts
- Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
- Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer